Skip to main content
NEUROTECH INTERNATIONAL LIMITED logo

NEUROTECH INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · NTI ISIN · AU000000NTI9 ASX Professional, scientific and technical activities
Filings indexed 667 across all filing types
Latest filing 2019-04-16 Director's Dealing
Country AU Australia
Listing ASX NTI

About NEUROTECH INTERNATIONAL LIMITED

https://neurotechinternational.com/

Neurotech International Limited is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for neurodevelopmental and neurological disorders. The company specializes in neuroprotective therapies, primarily targeting pediatric conditions with significant unmet medical needs, including Autism Spectrum Disorder (ASD), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). Its lead drug candidate, NTI164, is a proprietary, broad-spectrum cannabinoid formulation derived from a unique cannabis strain. NTI164 is engineered to exert anti-inflammatory and neuroprotective effects by modulating neuroinflammatory pathways. The company conducts clinical trials to establish the safety and efficacy of its treatments, aiming to provide transformative behavioral and functional improvements for patients.

Recent filings

Filing Released Lang Actions
Appendix 3Z - N Fong 2 pages 172.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the cessation of a director and the director's relevant interests in securities, with no securities held. This is a report of personal share transactions or holdings by a company director. The document length is short and focused solely on director interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2019-04-16 English
Appendix 3Z - P O'Connor 2 pages 172.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including holdings and options, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director. The document length is short and focused solely on director share interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2019-04-16 English
New Board Appointments 2 pages 174.4KB
Board/Management Information Classification · 95% confidence The document announces new appointments to the company's board and senior management positions, including an Independent Non-Executive Chairman, Independent Non-Executive Director, and Company Secretary. It also mentions retirements of previous directors and company secretary. The content focuses on changes in the company's board and management personnel, with no financial data, report references, or regulatory filings. This matches the definition of 'Board/Management Information' (MANG). The document length is about 5405 characters, sufficient for a detailed announcement but not a full report. Therefore, the correct classification is MANG with high confidence.
2019-04-15 English
Ceasing to be a substantial holder 3 pages 152.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in substantial shareholding interests, including dates and nature of changes, and is addressed to the Australian Stock Exchange. This type of filing is a notification of changes in significant share ownership levels, specifically ceasing to be a substantial holder. It is not a financial report, earnings release, or management discussion, but a regulatory notification about shareholding. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not just an announcement or certification.
2019-04-07 English
Dr Adrian Attard Trevisan, clarification 1 page 118
Regulatory Filings Classification · 95% confidence The document is a short announcement clarifying information about an individual, Dr Adrian Attard Trevisan, specifically correcting previous statements about his academic credentials and employment dates. It references a prior announcement but does not contain financial data, regulatory filings, or detailed reports. The length is only 2007 characters, indicating it is a brief announcement rather than a full report. There is no indication of financial results, management changes, or voting results. The content is a correction or clarification related to a prior announcement, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2019-03-27 English
Dr Adrian Attard Trevisan 2 pages 122.9KB
Regulatory Filings Classification · 95% confidence The document is a public announcement addressing concerns about the qualifications of a former strategic adviser and director, Dr Adrian Attard Trevisan. It clarifies his past roles, the company's stance on the issue, and provides background on the company's product and mission. There is no financial data, regulatory filing references, or report attachments. The content is a corporate communication addressing reputational and operational matters rather than a formal report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) since it is a miscellaneous announcement that does not fit other specific categories.
2019-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.